> Details

Shahtaheri, Rahill Sadat [Author]; Bayazidi, Yahya [Author]; Davari, Majid [Author]; Kebriaeezadeh, Abbas [Author]; Yousef, Sepideh [Author]; Mahdavi Hezaveh, Alireza [Author]; Sadeghi, Abolfazl [Author]; Al Lami, Ahmed Hayder Mohsin [Author]; Abbasian, Hadi [Author]

Long-term cost-effectiveness of quality of diabetes care : experiences from private and public diabetes centers in Iran

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Long-term cost-effectiveness of quality of diabetes care : experiences from private and public diabetes centers in Iran
  • Contributor: Shahtaheri, Rahill Sadat [VerfasserIn]; Bayazidi, Yahya [VerfasserIn]; Davari, Majid [VerfasserIn]; Kebriaeezadeh, Abbas [VerfasserIn]; Yousef, Sepideh [VerfasserIn]; Mahdavi Hezaveh, Alireza [VerfasserIn]; Sadeghi, Abolfazl [VerfasserIn]; Al Lami, Ahmed Hayder Mohsin [VerfasserIn]; Abbasian, Hadi [VerfasserIn]
  • imprint: 2022
  • Published in: Health economics review ; 12(2022), 1 vom: Dez., Artikel-ID 44, Seite 1-7
  • Language: English
  • DOI: 10.1186/s13561-022-00377-9
  • ISSN: 2191-1991
  • Identifier:
  • Keywords: Type 2 diabetes mellitus ; Localized UKPDS model ; Private sector ; Public sector ; Cost-efectiveness analysis,Quality of care ; Iran ; Aufsatz in Zeitschrift
  • Origination:
  • Footnote:
  • Description: Background: The quality of health care has a signifcant impact on both patients and the health system in terms of long-term costs and health consequences. This study focuses on determining the long-term cost-efectiveness in quality of diabetes care in two diferent settings (private/public) using longitudinal patient-level data in Iran. Methods: By extracting patients intermediate biomedical markers in under-treatment type 2 diabetes patients(T2DP) in a longitudinal retrospective study and by applying the localized UKPDS diabetes model, lifetime health outcomes including life expectancy, quality-adjusted Life expectancy (QALE) and direct medical costs of managing disease and related complications from a healthcare system perspective was predicted. Costs and utility decrements had derived on under-treatment T2DP from 7 private and 8 Public diabetes centers. We applied two steps sampling mehods to recruit the needed sample size (cluster and random sampling). To cope with frst and secondorder uncertainty, we used Monte-Carlo simulation and bootstrapping techniques. Both cost and utility variables were discounted by 3% in the base model. Results: In a 20-year time horizon, according to over 5 years of quality of care data, outcomes-driven in the private sector will be more efective and more costly (5.17 vs. 4.95 QALE and 15,385 vs. 8092). The incremental cost-efectiveness ratio (ICER) was $33,148.02 per QALE gained, which was higher than the national threshold. Conclusion: Although quality of care in private diabetes centers resulted in a slight increase in the life expectancy in T2DM patients, it is associated with unfavorable costs, too. Private-sector in management of T2DM patients, compared with public (governmental) diabetic Centers, is unlikely to be cost-efective in Iran.
  • Access State: Open Access
  • Rights information: Attribution (CC BY)